Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Akoya BioSciences, Inc. (AKYA)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $25.42 million, and the earnings are expected to come in at -$0.20 per share. The full year 2024's revenue is expected to be $98.20 million and the earnings are expected to be -$1.03 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 3 Warning Signs with AKYA. Over the past 90 days, revenue estimates for Akoya Biosciences Inc ( NASDAQ:AKYA ) have seen a slight decrease from $98.25 million to $98.20 million for the full year 2024, and from $118.59 million to $116.06 million for 2025. During the same period, earnings estimates have shown improvement, increasing from -$1.04 per share to -$1.03 per share for the full year 2024, and from -$0.60 per share to -$0.57 per share for 2025. In the previous quarter of June 30, 2024, Akoya Biosciences Inc's ( NASDAQ:AKYA ) actual revenue was $23.16 million, which missed analysts' revenue expectations of $23.55 million by -1.65%. Akoya Bioscienc
Show less
Read more
Impact Snapshot
Event Time:
AKYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKYA alerts
High impacting Akoya BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
AKYA
News
- Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.MarketBeat
- Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook [Yahoo! Finance]Yahoo! Finance
- Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $3.50. They now have a "buy" rating on the stock.MarketBeat
- Akoya Biosciences, Inc. (NASDAQ: AKYA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $5.00 price target on the stock, down previously from $7.00.MarketBeat
AKYA
Earnings
- 11/14/24 - Miss
AKYA
Sec Filings
- 11/21/24 - Form 4
- 11/21/24 - Form 4
- 11/21/24 - Form 4
- AKYA's page on the SEC website